As obtained for IBC, IBD patients also had robust detection of active RIPK2 (Figure 2A), at >2 fold, in biopsy sections from IBD patients vs. non-IBD patients, suggesting its importance in driving colonic inflammation in IBD patients. Here, RIPK2 is linked to inflammatory bowel disease.